原发性胆汁反流性胃炎治疗及其临床病理分析  

Treatment and clinicopathologic anlysis of Bile Reflux Gastritis(BRG)

作　　者：王志宁[1] 袁晓英[1] 

机构地区：[1]重庆市第九人民医院消化科,400700

出　　处：《重庆医学》2009年第10期1227-1228,1230,共3页Chongqing medicine

摘　　要：目的探讨多重治疗方法对原发性胆汁反流胃炎(BRG)的临床疗效,并对胆汁反流性胃炎进行病理分析。方法120例随机分为两组,铝碳酸镁、胃复春组(治疗组)和莫沙必利组(对照组)。结果从临床症状和胃镜检查来看,铝碳酸镁组的疗效高于莫沙必利组,其差异具有统计学意义(P<0.05)。结论铝碳酸镁、胃复春治疗胆汁反流性胃炎具有较高的疗效,可作为治疗和维持疗效的首选药,临床病理分析研究表明,BRG与胃黏膜肠化生、萎缩、异型增生有关。Objeetive To investigate therapeutic effect of several methods on bile reflux gastritis （BRG） and analyse the clinicopathologic of the disease. Methods 120 patients were divided into two groups in random, which were named group aluminum carbonic acid magnesium（ACCM） weifucbun and group cisapride. Results The therapeutic group was better than the contrast group obviously and it was confirmed by clinical syptoms and gastroscopic results. The difference was statistically significant（P〈0.05）. Conclusion It is a good method to cure BRG by ACCM and weifuchun,it may be the first choice for treatment of BRG. Clinicopathologie study showed that BRG was related to metaplasia,Atrophy and dysplasia of gastric mucosa.

关 键 词：胆汁反流性胃炎 铝碳酸镁 胃复春组 莫沙必利组 病理分析 

分 类 号：R573.3[医药卫生—消化系统]